(Reuters) -Shares of Indian generic drugmaker Dr Reddy's Laboratories declined more than 5% on Thursday, after the firm received a non-compliance notice for its semaglutide injection in Canada, which ...
News-Medical.Net on MSN
WHO reviews highlight limited long-term data on GLP-1 drug safety
Three new Cochrane reviews find evidence that GLP-1 drugs result in clinically meaningful weight loss, but industry-funded ...
Sometimes the greatest teacher you can have in life is your past experience, and that proved to be true for the second-seeded ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback